Summary:
Czech academic institution developed a new generation of cytokinins which have a very high anti-oxidant capacity and extend lifespan of C. elegans, a model organism frequently used in biogerontology research. License Agreement and research cooperation agreement is offered.
Description:
Czech academic institution developed a new generation of cytokinins. This invention provides novel compounds with strong antioxidant activity, exceeding those of standard cosmetics (pyratine, retinol). These compounds can be formulated as anti‐aging, anti-acne rosacea and can be also used as eczema treatment. Novel compounds with strong antioxidant activity, exceeding those of standard active substances used in cosmetics (pyratine, retinol, ascorbic acid).
The compounds can be formulated as anti‐aging, anti‐rosacea and anti‐eczema cosmeceuticals or drugs.
The technology needs to be licenced to some pharmaceutical or cosmetic company, with knowledge how to develop the technology and with possibly to get on market. The academic institution offers license agreement or research cooperation agreement.
The research task is to find and test the possibilities of joining the new compound with a suitable cosmetic medium.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
License Agreement and reseach cooperation agreement is offered. Czech academic research institution is looking for research or business institution which would help to develop the product to clinical trial or get the substance to the market. They are able to provide information´s from preclinical phase.
Stage of Development:
Under development/lab tested
Comments Regarding Stage of Development:
Synthesis in the laboratory scale (>98%, NMR, HPLC‐MS, elemental). Experimental data on anti‐oxidant and anti‐aging aktivity. Preclinical characterization underway. Small clinical study underway.
IPR Status:
Secret Know-how,Patent(s) applied for but not yet granted
External code:
TOCZ20170724002
